Please assess the completion status of the following clinical trial:

Trial Title: Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Active Duty Service Members with Pseudofolliculitis Barbae~Exclusion Criteria:~* Previous treatment with laser hair removal in the previous 12 months, Currently pregnant, seeking pregnancy, or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Paired(right and left neck) comparison group eflornithine (Type: ACTIVE_COMPARATOR): randomized, double-blinded, placebo-controlled, paired (right and left neck) comparison study examining eflornithine versus placebo for the treatment of PFB.
- Paired(right and left neck) comparison group placebo (Type: PLACEBO_COMPARATOR): randomized, double-blinded, placebo-controlled, paired (right and left neck) comparison study examining eflornithine versus placebo for the treatment of PFB.

Based on this trial design, predict the completion outcome and termination type (if applicable).